LAURAMINE

Dodecylamine is a primary aliphatic amine.

Fuente: PubChem

Registro de sustancias de la FDA (EE. UU.) · UNII YWY9OD6A2K · nombre registrado DODECYLAMINE · sustancia química única

Fuente: Identificador único de ingredientes de la FDA (UNII)

Restringido o prohibido

China · Corea del Sur

Fuente: Información regulatoria cosmética del MFDS (Corea)

Argentina · Brasil

• Maximum concentration permitted at final product : Under maximum secondary amine: 0.5%
• Other limitations and requirements : No use with nitrosating systems. Minimum 99% -Pureza. Maximum -Tenor of secondary amines in raw materials 0.5%. Maximum nitrosamine -Tenor: 50 ug / kg. -Envasar / Nitrite - free store in containers.

ASEAN

• Maximum authorised concentration in the finished cosmetic product : Maximum secondary amine content: 0.5%
• Other limitations and requirements : • Do not use with nitrosating systems • Minimum purity: 99% • Maximum secondary amine content: 0.5% (applies to raw materials) • Maximum nitrosamine content: 50 μg/kg • Keep in nitrite-free containers

Unión Europea

• Maximum concentration in ready for use preparation : Maximum secondary amine content: 0.5%
• Other : - Do not use with nitrosating systems - Minimum purity: 99% - Maximum secondary amine content: 0.5% (applies to raw materials) - Maximum nitrosamine content: 50 microgram/kg - Keep in nitrite-free containers

Sin clasificación en la lista GHS de sustancias tóxicas de Corea · sustancia química existente

Fuente: Registro GHS de sustancias tóxicas de Corea (NIER)

Restriction III/61

Fuente: Lista de ingredientes CosIng (UE)

Reviewed by CIR: Final Report on the Safety Assessment of Lauramine and Stearamine

Fuente: Cosmetic Ingredient Review (CIR, EE. UU.)

CIR reviewed this ingredient and flagged its status as: Insufficient data ingredients with no uses reported to FDA's Voluntary Cosmetic Registration Program (VCRP) (insufficient data or use not supported — CIR's own classification, not a full safety-as-used conclusion).

Fuente: Cosmetic Ingredient Review (CIR, EE. UU.)